ARTICLE | Company News
Millennium, Cytos small molecule deal
December 6, 2001 8:00 AM UTC
MLNM acquired rights from Cytos (Zurich, Switzerland) to screen for small molecules and other drug entities using Cytos' DELphi high throughput functional genomics technology. MLNM also may develop an...